Articles by Kholoud Porter

Commonly prescribed antiretroviral therapy regimens and incidence of AIDS-defining neurological conditions

Caniglia, Ellen C.; Phillips, Andrew; Porter, Kholoud; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. ., Post Acceptance: October 04, 2017

Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older

Lodi, Sara; Costagliola, Dominique; Sabin, Caroline; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 76(3):311-318, November 1, 2017.

Virological Blips and Predictors of Post Treatment Viral Control After Stopping ART Started in Primary HIV Infection

Fidler, Sarah; Olson, Ashley D.; Bucher, Heiner C.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(2):126-133, February 1st, 2017.

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

Thornhill, John; Inshaw, Jamie; Kaleebu, Pontiano; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 73(1):69-73, September 1st, 2016.

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death

Olson, Ashley D.; Walker, A. Sarah; Suthar, Amitabh B.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 73(1):100-108, September 1st, 2016.

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype

Olson, Ashley D.; Guiguet, Marguerite; Zangerle, Robert; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(1):15-21, September 1st, 2014.

Rate of CD4 Decline and HIV-RNA Change Following HIV Seroconversion in Men Who Have Sex With Men: A Comparison Between the Beijing PRIMO and CASCADE Cohorts

Huang, Xiaojie; Lodi, Sara; Fox, Zoe; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(4):441-446, April 1st, 2013.

The Impact of Transmitted Drug-Resistance on Treatment Selection and Outcome of First-Line Highly Active Antiretroviral Therapy (HAART)

Bansi, Loveleen; Geretti, Anna Maria; Dunn, David; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(5):633-639, April 15th, 2010.

Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study

Bansi, Loveleen; Turner, Jo; Gilson, Richard; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(3):391-396, November 2009.

Rates and Determinants of Virologic and Immunological Response to HAART Resumption After Treatment Interruption in HIV-1 Clinical Practice

Touloumi, Giota; Pantazis, Nikos; Stirnadel, Heide A; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(5):492-498, December 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(2):202-205, February 1st, 2008.

Highly Active Antiretroviral Therapy Interruption: Predictors and Virological and Immunologic Consequences

Touloumi, Giota; Pantazis, Nikos; Antoniou, Anna; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 42(5):554-561, August 15th, 2006.

Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance Algorithms: Data From Seroconverters in the CASCADE Collaboration From 1987 to 2003

Masquelier, Bernard; Bhaskaran, Krishnan; Pillay, Deenan; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(5):505-511, December 15th, 2005.